Altered performance in attention tasks in patients with seasonal allergic rhinitis: seasonal dependency and association with disease characteristics by Trikojat, K. et al.
 
 
 
 
 
Dieses Dokument ist eine Zweitveröffentlichung (Verlagsversion) / 
This is a self-archiving document (published version):  
 
 
 
 
 
 
 
 
 
 
Diese Version ist verfügbar / This version is available on:  
https://nbn-resolving.org/urn:nbn:de:bsz:14-qucosa2-389915 
 
 
 
„Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFGgeförderten) Allianz- bzw. 
Nationallizenz frei zugänglich.“ 
 
This publication is openly accessible with the permission of the copyright owner. The permission is granted 
within a nationwide license, supported by the German Research Foundation (abbr. in German DFG). 
www.nationallizenzen.de/ 
 
K. Trikojat, A. Buske-Kirschbaum, J. Schmitt, F. Plessow 
Altered performance in attention tasks in patients with seasonal 
allergic rhinitis: seasonal dependency and association with disease 
characteristics 
Erstveröffentlichung in / First published in: 
Psychological Medicine. 2015, 45(6), S. 1289 – 1299 [Zugriff am: 13.03.2020]. Cambridge 
University Press. ISSN 1469-8978. 
 
DOI: https://doi.org/10.1017/S0033291714002384 
  
Altered performance in attention tasks in patients
with seasonal allergic rhinitis: seasonal dependency
and association with disease characteristics
K. Trikojat1*, A. Buske-Kirschbaum1, J. Schmitt2 and F. Plessow1,3
1Department of Psychology, Technische Universität Dresden, Germany
2Centre for Evidence-Based Healthcare, University Hospital Carl Gustav Carus Dresden, Germany
3Berenson-Allen Center for Noninvasive Brain Stimulation, Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical
School, Boston, MA, USA
Background. Seasonal allergic rhinitis (SAR) is a chronic disease affecting about 23% of the European population with
increasing prevalence rates. Beside classical symptoms (i.e. sneezing, nasal congestion), patients frequently complain
about subjective impairments in cognitive functioning during periods of acute allergic inflammation. However, objective
evidence for such deficits or the role of potential modulators and underlying mechanisms is limited. The present study
aimed to investigate the effect of SAR on attention-related cognitive processes. In addition, relationships between atten-
tion performance, sleep and mood disturbances as well as specific disease characteristics as potential modulators of this
link were explored.
Method. SAR patients (n = 41) and non-allergic healthy controls (n = 42) completed a set of attention tasks during a
symptomatic allergy period and during a non-symptomatic period. Influences of sleep, mood, total immunoglobulin
E (IgE) levels and individual allergy characteristics on cognitive performance were evaluated.
Results. Compared to healthy controls, SAR patients had a slower processing speed during both symptomatic and non-
symptomatic allergy periods. Additionally, they showed a more flexible adjustment in attention control, which may
serve as a compensatory strategy. Reduction in processing speed was positively associated with total IgE levels whereas
flexible adjustment of attention was linked with anxious mood. No association was found between SAR-related attention
deficits and allergy characteristics or sleep.
Conclusions. SAR represents a state that is crucially linked to impairments in information processing and changes in
attentional control adjustments. These cognitive alterations are more likely to be influenced by mood and basal inflam-
matory processes than sleep impairments or subjective symptom severity.
Received 15 April 2014; Revised 28 August 2014; Accepted 3 September 2014; First published online 2 October 2014
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Introduction
Seasonal allergic rhinitis (SAR) is a highly prevalent
chronic disease affecting about 23% of the adult
European population with increasing, almost ‘en-
demic’, prevalence rates (Bauchau & Durham, 2004;
Bousquet et al. 2008a). SAR is clinically defined as
an immunoglobulin E (IgE)-mediated inflammation
of the nasal mucosa in reaction to allergens and is char-
acterized by symptoms including itching, sneezing,
rhinorrhea and nasal obstruction. Beside these classical
symptoms, a substantial number of patients complain
about accompanying problems such as reduced
physical and mental capacity and subdued mood
(Kremer et al. 2002; Marshall et al. 2002; Meltzer et al.
2009; Virchow et al. 2011). After being neglected for a
long time, these secondary psychological side-effects
of allergic disorders have recently been shifting into
the focus of both public awareness and research.
In initial studies using a naturalistic design, SAR
patients reported significantly more subjective feelings
of insufficiency in thinking and acting (Kremer et al.
2002) and problems in paying attention or slowed
thinking during the allergy season (Marshall et al.
2000). These statements are conceivably related to
impairments in underlying cognitive functions asso-
ciated with attention and adaptive control. These func-
tions include the allocation of processing resources,
their maintenance and adjustments to optimize per-
formance, particularly when faced with conflicts and
rapidly changing environments. However, objective
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evidence for deficits in these functions has so far been
difficult to obtain under natural conditions, and the
few available findings are inconsistent (Marshall &
Colon, 1993; Marshall et al. 2000; Kremer et al. 2002).
In a laboratory setting, two studies revealed decre-
ments in corresponding cognitive functions (i.e. sus-
tained attention, working memory, divided attention)
using allergen challenges to experimentally evoke
symptoms (Wilken et al. 2002; Hartgerink-Lutgens
et al. 2009). In the study by Hartgerink-Lutgens et al.
(2009), SAR patients even showed a reduction in pro-
cessing speed irrespective of allergen challenge, indi-
cating that at least some cognitive changes might be
of a lasting nature. This study also demonstrated that
patients reported comparatively more subjective men-
tal effort in short or easy tasks, suggesting that patients
used increased compensatory and control strategies to
overcome allergy-induced deficits. These laboratory
studies provide valuable results on the impact of al-
lergic stimulation on cognition and are unrivaled in
their quality of experimental manipulation and control.
However, they encounter limits in assessing the com-
plexity of the real-life burden of SAR. Laboratory
findings are further limited to acute allergic reactions,
and do not capture the potential effects of chronic aller-
gen exposure and the time course of potential impair-
ments resulting from acute periods. To address these
questions, naturalistic studies aligned to a high labora-
tory standard are needed.
Beside these methodological concerns, it is import-
ant to note that relevant mediating factors (e.g.
allergy-related sample characteristics, sleep and mood
variables) have been neglected in the majority of stu-
dies. Allergy-related sample characteristics include in-
dividually distinctive aspects of allergic disease, such
as symptom severity, biological markers of allergic
sensitization (i.e. total IgE level), the duration of al-
lergic symptomatology per year, and the time since in-
itial disease manifestation. It is likely that symptom
severity could affect cognitive test performance di-
rectly due to watery eyes, sneezing or a runny nose,
or indirectly through poor sleep due to nasal conges-
tion (Virchow et al. 2011; Thompson et al. 2013).
Allergy-relevant immunological processes could also
be involved. IgE, the initial antibody provoking the
cascade of allergic reactions through histamine release,
has been associated with depressive mood in atopic
and bipolar disorders (Timonen et al. 2003; Manalai
et al. 2012). Long duration of disease and symptoma-
tology could exhaust a patient’s resources and result
in changes of behavioral adaptation. SAR-induced
sleep disturbances and worsening of mood in subjects
with SAR during the pollen season have been repeat-
edly confirmed (Marshall & Colon, 1993; Marshall
et al. 2002; Muliol et al. 2008; Koinis-Mitchell et al.
2012); both significantly contribute to performance in
memory, cognitive control and attention (Bower,
1981; Belenky et al. 2003; van Steenbergen et al. 2010;
Benitez & Gunstad, 2012).
Based on previous research, the current study aimed
to investigate the influence of SAR on performance
under naturalistic conditions during a symptomatic
and a non-symptomatic allergy period. Earlier findings
in laboratory settings revealed significant effects of al-
lergy on attentional functions (e.g. sustained attention,
selective attention and processing speed) and those ef-
fects largely correspond with the self-reported difficul-
ties of SAR patients. Accordingly, we focused on the
assessment of functions related to attention with the
aim of replicating and extending previous knowledge
of SAR-induced impairments in sustained attention,
selective attention and processing speed. In addition,
to determine whether the regulation of effort to situa-
tional demands changes in SAR patients, dynamic
aspects of attentional control (i.e. the ability to flexibly
adjust attention and action to varying situational
demands) were assessed.
In addition to potential alterations in attentional
processes, we aimed to identify whether changes
observed in SAR subjects are transient (e.g. limited to
the manifestation of allergic symptoms) or stable (e.g.
also detectable in non-symptomatic periods). We also
focused on the influence of mediating mood, sleep
and allergy factors. We predicted that with increasing
severity of symptoms (along with mood and sleep
worsening), potential impairments in attention and
attention-related cognitive processes would be
amplified.
Method
Study design
Forty-one patients suffering from SAR and 42 healthy,
non-allergic participants were assessed in a longitudi-
nal study performed between February and
December 2012. Subjects were assessed during a symp-
tomatic allergy period (‘on-season’) and also during a
non-symptomatic period (‘off-season’). During the pol-
len season (March to October 2012), on-season assess-
ment took place after patients experienced at least 2
weeks of allergic complaints (nasal congestion, rhinor-
rhea, sneezing, red or watery eyes; assessed using a
symptom diary). All patients were off allergy medi-
cation (i.e. systemic or topical antihistamines, corticos-
teroids or mast cell stabilizers) at least 7 days prior to
testing. To prevent possible sequence effects, the first
testing condition (on-season versus off-season) was
balanced across subjects, and a minimum time interval
of 3 months between the two assessments was defined.
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The non-allergic control group was added to monitor
potential effects other than allergy on the outcome
variables and was treated in the same way as the
SAR group. Assignment to testing condition in the
control group was semi-randomized with test sessions
in January, February, November and December being
automatically classified as off-season to uncover poten-
tial allergy-independent seasonal variations in the
assessed parameters (e.g. due to shorter days during
winter). All SAR patients were clinically diagnosed
by an allergist and had a positive skin prick test for
at least one grass or tree pollen and/or an elevated
total IgE level (>100 IU/ml serum), validating the diag-
nosis of SAR. SAR patients with current or recent
immunotherapy or other perennial allergies were
excluded from the study. Control subjects had no his-
tory of any atopic disorder and a negative skin prick
test and/or low total IgE status (<100 IU/ml serum).
As factors other than allergic hypersensitivity (e.g.
parasites) could also account for increased IgE levels,
if a subject showed increased IgE levels or a positive
skin prick test for a single allergen but had never ex-
perienced any allergic symptoms, they remained in
the control group. General inclusion criteria were:
age between 18 and 45 years, no diagnosed psychiatric
or central nervous system disease, no use of interfering
medication, and no visual or auditory impairment that
could disturb examination. The study was approved
by the local ethics committee and written informed
consent was obtained from all participants.
Assessment of allergy-related factors and symptom
severity
Symptomseveritywas assessedwith visual analog scales
(VAS-SAR, according to Bousquet et al. 2008b; see also
Buske-Kirschbaum et al. 2010). For 10 items, patients
rated the severity of nasal, eye and behavioral symptoms
ranging from zero (not at all) to 100 (very strong). The
sum score of all items was used as an overall indicator
of symptom severity (Buske-Kirschbaum et al. 2010).
Additional disease-related factors suchasdurationofdis-
ease, age at disease manifestation and number of days
with allergic symptoms prior to day of testing were eval-
uated by patients’ self-report. The standardized form of
the Rhinoconjunctivitis Quality of Life Questionnaire
(RQLQ-S, Juniper et al. 1999) was used to measure
symptom-related disturbances in SAR sufferers in daily
life. The RQLQ-S consists of 28 items on seven domains
(nasal symptoms, ocular symptoms, general symptoms,
sleeping disorders, practical problems, limitations of ac-
tivity and emotional disorders). Scores ranged from 0
(not impaired at all) to 6 (severely impaired). The overall
RQLQ score was calculated from the mean values of the
28 items. The Multidimensional Mood Questionnaire
(Mehrdimensionaler Befindlichkeitsfragebogen, MDBF;
Steyer et al. 1997) is a 24-item self-report measure that
assesses current mental state on three dimensions:
valence, alertness and calmness. The State Anxiety ver-
sion of the State–Trait Anxiety Inventory (STAI-S; Laux
et al. 1981) was applied to further focus on anxious
mood aspects. Using 20 items, subjects rated their
emotional state on a four-point Likert scale. The
Pittsburgh Sleep Quality Index (PSQI; Buysse et al.
1989) was used to examine the effects of allergy on
sleep parameters. In the PSQI, 19 items assess individual
sleep quality, sleep latency, sleep duration, habitual sleep
efficiency, sleep disturbances, use of sleep medication,
and daytime dysfunction during the past 2 weeks.
Total IgE
A blood sample was obtained from each subject during
on-season and off-season testing. Total serum IgE con-
centrations were determined using an enzyme-linked
immunosorbent assay (ELISA; IBL, Germany) accord-
ing to the manufacturer’s instructions.
Assessment of cognitive performance
Cognitive performance was assessed with the
Continuous Performance Task (CPT; Knye et al. 1996)
and the Simon task (Simon, 1990). The CPT is a
computer-based standard task assessing sustained
selective attention, psychomotor speed and impulsiv-
ity. Single letters were presented sequentially each se-
cond on a black screen. Subjects were instructed to
immediately respond to the sequence of ‘O’ directly
followed by ‘X’ while ignoring all other sequences.
The overall duration of the task including a training
phase was 17 min. Contrasting the performance in
the first and second halves of the task provided infor-
mation about the ability to sustain attention over a
longer period [reaction time (RT) and error indices],
while mean RT served as a measure of overall psycho-
motor speed. Omission errors (i.e. missing a
‘O-followed-by-X’ target sequence) and commission
errors (i.e. responses to irrelevant non-target
sequences) were analyzed as markers of selective at-
tention and impulsivity respectively.
The Simon task represents a standard measure of
more demanding attentional processes. By initiating
a response conflict, it assesses the distractibility from
task-irrelevant stimuli and flexibility in attentional
control adjustments. We used a numerical version of
the Simon task (Fischer et al. 2008; Plessow et al.
2011): target stimuli (digits 1–9 excluding 5) were pre-
sented either to the left or right of the screen center on
a 17-inch monitor attached to an IBM-compatible per-
sonal computer. Subjects were instructed to respond
to the identity of the presented target by manual key
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presses (‘press left key for digits smaller than five and
press right key for digits larger than five’) irrespective
of its location on the screen (i.e. right versus left side).
Although the stimulus location has no task relevance,
it automatically triggers the activation of the spatially
corresponding response (e.g. a target presented on
the left automatically activates a left response).
Depending on the correspondence of stimulus
location and required response key (based on stimulus
identity), non-conflicting compatible (C; e.g. target ‘1’
presented on the left screen side requires a left key
press) and incompatible trials (I; i.e. target ‘1’ dis-
played on the right screen side requires a left key
press) are derived. In incompatible trials, this auto-
matic activation needs to be overcome, resulting in
additional performance costs (i.e. slower responses
and/or increased error rates). This compatibility effect
reflects the individual susceptibility to interference.
Additionally, the sequential analysis of trials reveals
that conflicting trials increase the attentional control
for subsequent trials, resulting in a decreased compati-
bility effect in trials following an incompatible conflict
trial compared to non-conflicting compatible trials
(conflict adaptation effect; Gratton et al. 1992;
Stürmer et al. 2002). Each trial started with a centrally
displayed fixation cross. After 1000 ms, targets were
shown either 2.8 cm to the left or to the right of the
fixation sign for 200 ms. Once a response was given
(or following a response window of 1800 ms maxi-
mum after target onset), the fixation cross disap-
peared. Performance feedback was given for
incorrect responses or misses (‘false’, ‘too slow’) for
300 ms. After a correct response a blank screen was
shown for 300 ms. All trials finished with a blank
screen for a random interval between 100 ms and
1000 ms. All subjects performed a practice block con-
sisting of 16 trials and three test blocks with 64 trials
each (total number of test trials: 192). Presentation
software version 0.71 (Neurobehavioral Systems,
Inc., USA) was used for stimulus presentation and
data recording.
Data analysis
To evaluate changes in mood and cognitive perform-
ance across the two testing sessions, a series of two-
way ANOVAs with the between-subject factor group
(SAR patients versus healthy controls) and the within-
subject factor season (on-season versus off-season)
were conducted for CPT RT, RT and error indices,
omission and commission error rates and also for
PSQI, MDBF, STAI-S and total IgE levels. For signifi-
cant group × season interactions on a p < 0.05 level,
post-hoc analyses using independent t tests were ap-
plied to further compare group performance within a
particular season and paired t tests to evaluate per-
formance differences within one group across testing
sessions. In the case of multiple comparisons due to in-
teraction effects, p values were Bonferroni corrected.
Because of lack of normal distribution, rank-
transformed total IgE levels were used for further
calculations.
For the Simon task, four-way repeated-measures
ANOVAs with compatibility of the current trial
(n; compatible versus incompatible), compatibility of
the previous trial (n− 1; compatible versus incompat-
ible) and season (on-season versus off-season) as
within-subject factors and group (SAR patients versus
healthy controls) as the between-subject factor were
conducted for mean RTs and percentage of error
rates. Furthermore, indices of the compatibility effect
(I – C) and conflict adaptation [(cI – cC) – (iI – iC);
with lowercase letters representing compatibility (c)
or incompatibility (i) in the previous trial] were calcu-
lated (see van Steenbergen et al. 2010). The first trial of
each block (2.4%), trials with identical target repeti-
tions (7.23%), and post-error trials (3.5%) were
excluded from all Simon task analyses. For RT analysis
only, errors and RTs differing by more than 2.5 S.D.
from each individual’s condition-specific mean (6.1%)
were also excluded. All statistical tests were performed
at a 0.05 level of significance. To explore associations
between cognitive performance and disease-related
factors, Spearman correlations between the cognitive
outcome measures and allergy characteristics, total
IgE level during on-season, mood and sleep variables
were conducted and linear regressions for significant
correlations were applied.
Results
Demographic characteristics, self-reported measures
and IgE levels
Demographic and allergy characteristics are displayed
in Table 1. Groups did not differ regarding age, gender
and body mass index (BMI). Groups also did not differ
in the highest level of education. However, during
on-season testing, SAR patients differed significantly
from healthy controls in parameters of sleep and alert-
ness and in total IgE levels. Compared to healthy con-
trols, SAR patients experienced poorer sleep quality
and increased daytime sleepiness and fatigue.
Furthermore, significantly increased total IgE levels
were found in SAR subjects during the allergy season.
As expected, SAR patients showed significant worsen-
ing in symptom severity and quality of life in the
on-season testing when compared to the off-season
testing. An increase in state anxiety was also observed
in patients during on-season testing.
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Table 1. Demographic characteristics and self-reported measures
Demographics SAR patients (n = 41) Healthy controls (n = 42) Statistics: p value
Age (years), mean (S.D.) 24.1 (3.3) 24.4 (3.1) 0.662
Male, n (%) 21 (51) 20 (48) 0.876
BMI, mean (S.D.) 23.0 (2.5) 22.6 (2.0) 0.473
Level of education, mean (S.D.) 3.3 (0.6) 3.1 (0.4) 0.159
Days with allergy symptoms, mean (S.D.) 16.5 (11.5)
Number of allergies, mean (S.D.) range 5.4 (2.0) 1–8
SAR duration (years), mean (S.D.) range 12.5 (5.8) 3–27
Age allergy manifestation (years), mean (S.D.) 11.6 (5.7)
Self-reported measures
SAR patients (n = 41) Healthy controls (n = 42) Statistics: p value
On-season Off-season On-season Off-season Season effect Group effect Group × season t test on-season
Allergy characteristics
Symptom severity 369 (170) 44 (27) < 0.001
RQLQ 68.0 (24.9) 3.0 (3.9) < 0.001
Rank of total IgE levels 50.9 (19.1) 49.9 (19.7) 30.2 (22.2) 28.9 (22.7) N.S. < 0.001 N.S. < 0.001
Mood
MDBF valence 17.9 (1.7) 18.3 (1.8) 17.9 (2.0) 17.9 (1.8) 0.024 N.S. N.S. N.S.
MDBF calmness 16.4 (2.1) 17.1 (2.4) 16.5 (2.7) 16.4 (2.4) 0.027 N.S. N.S. N.S.
MDBF alertness 14.7 (3.3) 15.8 (3.8) 16.0 (2.8) 15.5 (3.0) N.S. N.S. 0.033 0.038
STAI-S 32.1 (5.6) 29.8 (5.8) 32.0 (7.1) 31.2 (6.0) 0.010 N.S. N.S. N.S.
Sleep
PSQI sum score 5.9 (2.8) 4.6 (2.4) 4.4 (2.7) 4.6 (2.9) N.S. N.S. 0.044 0.019
PSQI sleep quality 1.2 (0.7) 0.9 (0.5) 0.7 (0.6) 0.8 (0.6) N.S. 0.004 0.017 < 0.001
PSQI sleep latency 1.7 (1.5) 1.6 (2.1) 1.6 (1.7) 1.7 (1.6) N.S. N.S. N.S. N.S.
PSQI sleep disturbances 1.1 (0.4) 0.9 (0.3) 0.9 (0.3) 0.9 (0.4) N.S. N.S. N.S. N.S.
PSQI sleep duration 0.2 (0.5) 0.2 (0.4) 0.1 (0.4) 0.2 (0.6) N.S. N.S. N.S. N.S.
PSQI sleep efficacy 0.4 (0.6) 0.3 (0.5) 0.2 (0.5) 0.3 (0.6) N.S. N.S. N.S. N.S.
PSQI sleep medication 0.1 (0.4) 0.0 (0.2) 0.1 (0.3) 0.0 (0.2) N.S. N.S. N.S. N.S.
PSQI day sleepiness 1.2 (0.8) 0.7 (0.7) 0.8 (0.7) 0.6 (0.6) < 0.001 0.036 N.S. 0.018
SAR, Seasonal allergic rhinitis; BMI, body mass index; RQLQ, Rhinoconjunctivitis Quality of Life Questionnaire; IgE, immunoglobulin E; MDBF, Multidimensional Mood
Questionnaire; STAI-S, State Anxiety version of the State–Trait Anxiety Inventory; PSQI, Pittsburgh Sleep Quality Index; N.S., non-significant.
Values are given as mean (S.D.) unless stated otherwise;
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Cognitive performance
CPT
Values for mean RTs, error rates and indices are listed
in Table 2. There was a significant main effect in mean
RT between groups (F1,81 = 7.78, p = 0.007, η
2 = 0.09),
with SAR patients showing reduced processing speed
during on-season (p = 0.005) and also during off-season
(p = 0.04, one-tailed) compared to healthy controls (see
Fig. 1a). No season or interaction effect could be found
for mean RT (p’s > 0.22). Additionally, no effects of
group, season or interaction for omission and com-
mission errors and for RT and error indices (all p’s >
0.149) were observed.
Simon task
Values for mean RTs and percentage of error rates are
listed in Table 3. Analysis of mean RTs showed a
significant main effect for compatibilityn (F1,81 = 71.30,
p < 0.001, η2 = 0.47) and an interaction effect for conflict
adaptation, compatibilityn × compatibilityn−1 (F1,81 =
434.00, p < 0.001, η2 = 0.84). No interaction effects of
compatibilityn or conflict adaptation with group and/
or season were found (p’s > 0.110). However, there
was a significant interaction between group and season
on mean RT (F1,81 = 6.42, p = 0.013, η
2 = 0.07).
Irrespective of task condition, SAR patients responded
substantially slower than healthy controls at on-season
(p = 0.001) and also to a lesser extent at off-season test-
ing (p = 0.045, one-tailed; Fig. 1a). The significance of
the Simon effect (F1,81 = 29.27, p < 0.001, η
2 = 0.27) and
conflict adaptation (F1,81 = 85.40, p < 0.001, η
2 = 0.51)
could also be demonstrated in the analysis of error
rates. However, there was a significant four-way inter-
action between conflict adaptation, group and season
(F1,81 = 5.19, p = 0.025, η
2 = 0.06). Post-hoc comparisons
indicated a higher adaptation during on-season and a
reduced adaptation effect off-season in the SAR
group (p = 0.02) (Fig. 1b). No change in conflict adap-
tation in healthy controls was observed (p’s5 0.195).
Post-hoc group comparisons for respective testing ses-
sions failed to reach significance (on-season: p = 0.253;
off-season: p = 0.195). No other significant interactions
with season and/or group were detected (all p’s5
0.377).
Correlation analysis revealed a positive association
between the observed conflict adaptation effects in
error rates and STAI-S scores (r = 0.34, p = 0.002;
Fig. 2c) and also in PSQI sleep quality scores (r = 0.23,
p = 0.042) for on-season testing (data not shown). In a
subsequent linear regression analysis including the fac-
tors STAI-S and PSQI sleep quality, only STAI-S
proved to be a significant predictor of conflict adap-
tation (corrected R2 = 0.09, p = 0.003; p = 0.254 for PSQI
sleep quality). Furthermore, we found positive associa-
tions between total IgE levels and mean RT in the
Simon task (r = 0.24, p = 0.029; Fig. 2b) and mean RT
in CPT (r = 0.27, p = 0.015; Fig. 2a). No relationship of
symptom severity, allergy duration, age of disease
manifestation or allergy-related quality of life with cog-
nitive performance during the symptomatic allergy
season could be demonstrated (p’s5 0.141).
Discussion
In this study we investigated performance in attention
and dynamic attention control processes, and their po-
tential determinants in patients with SAR and healthy
controls during symptomatic and non-symptomatic al-
lergy periods. The results provide substantial evidence
for a reduction in psychomotor speed in SAR patients
that persisted even in the absence of allergy symptoms.
Furthermore, patients showed altered patterns of
attentional control adjustments and a higher recruiting
of cognitive control during the symptomatic period,
whereas control adjustments were reduced during
Table 2. Performance on the Continuous Performance Task (CPT)
SAR patients (n = 41) Healthy controls (n = 42)
On-season Off-season On-season Off-season
RT (ms) 467 (14) 454 (14) 407 (14) 419 (14)
Omission error 0.5 (0.1) 0.7 (0.1) 0.6 (0.1) 0.5 (0.1)
Commission error 1.4 (0.2) 1.1 (0.2) 1.1 (0.2) 1.2 (0.2)
RT index 5.7 (1.8) 7.0 (2.0) 4.0 (1.7) 4.0 (2.0)
Omission error index 0.3 (0.1) 0.1 (0.1) 0.0 (0.1) 0.1 (0.1)
Commission error index 0.2 (0.2) −0.2 (0.2) −0.4 (0.2) −0.1 (0.2)
SAR, Seasonal allergic rhinitis; RT, reaction time.
Values are given as mean (standard error).
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the non-symptomatic period. Allergy-induced per-
formance changes were found to be related to IgE
levels and mood, rather than subjective symptom com-
plaints. These results contribute significantly to our
understanding of SAR by identifying specific cognitive
processes that are altered in patients with SAR under
naturalistic conditions. Furthermore, they highlight
the importance of looking beyond acute performance
consequences and, for the first time, they provide evi-
dence for an association of mood and IgE with these
cognitive changes in SAR.
In comparing the performances of SAR patients with
healthy controls, our first main finding is that patients
show diminished performance in a sustained attention
task during a symptomatic allergy period. This result
supports the reported subjective complaints of allergy
patients (Marshall et al. 2000) and previous studies
that also detected poorer performance of SAR patients
in a laboratory setting (Wilken et al. 2002;
Hartgerink-Lutgens et al. 2009). These studies all
used overall RT and error analysis as major outcomes.
Given that vigilance is defined as sustaining selective
attention over a longer period of time, impairments
would be expected to initially occur during middle
or late phases of task processing. Therefore, we
hypothesized that contrasting performances in the
first and second halves of the tests would be a superior
outcome measure. Against our expectations, there was
no decrease in performance during the course of task
processing. Instead, observed curtailments seemed to
develop at the outset and may be somewhat better
interpreted as a reduction in the speed of processing
and/or reaction to task-relevant stimuli (i.e. impair-
ment in psychomotor speed). Furthermore, this re-
duction in psychomotor speed persisted even in
non-symptomatic allergy periods, which might reflect
a stable cognitive deficit in SAR patients. However,
no performance decrements in SAR patients were
found for the applied measures of selective attention
(i.e. omission errors in CPT) and impulsivity (i.e. com-
mission errors in CPT).
Although no significant impairments in the ability to
shield attention from conflicting task-irrelevant stimuli
(i.e. the Simon effect) were found, the results from the
applied Simon paradigm also support the assumption
of stable psychomotor speed deficits in SAR patients.
Specifically, we found a similar general reduction in
RT irrespective of task condition (i.e. compatible versus
incompatible trials) and season in SAR patients
compared to healthy controls during performance of
the Simon task. By using a naturalistic design, we
therefore confirm a previous observation made by
Fig. 1. (a) Mean reaction times (in ms) in the Continuous Performance Task (CPT) and the Simon task for patients with
seasonal allergic rhinitis (SAR) and healthy controls (HC) at both testing points (on-season versus off-season). (b) Conflict
adaptation effects as percentage error (PE) in the Simon task for SAR patients and HC on-season versus off-season. Error bars
indicate standard errors of the mean. *p < 0.05, + p < 0.05 (one-tailed).
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Hartgerink-Lutgens et al. (2009), who reported slower
reactions of SAR patients in a motor choice reaction
task irrespective of symptom provocation.
A further major finding of the present study is the
season-dependent change in the adjustment of atten-
tional control. During symptomatic allergy periods,
patients showed an increase in conflict adaptation.
Accordingly, after processing a conflict (e.g. incom-
patible conflict trial), patients were more able to
diminish the influence of task-irrelevant information
(e.g. stimulus location) on the subsequent trial,
which was not observed after non-conflicting trials.
This indicates a highly flexible, exaggerated up-
and down-regulation of (selective) attention based
on environmental signals. On more speculative
terms, this higher flexibility in the recruitment and
regulation of attentional resources during acute
allergy phases could represent a compensatory
strategy to cover detriments caused by allergic
rhinitis and could therefore be linked with the
debate of increased mental effort in SAR patients.
This assumption would be in line with Hartgerink-
Lutgens et al. (2009), who propose that the capacity
to enhance attentional control will only be exhausted
if task demands are too high or a high level of per-
formance has to be maintained for too long. In this
scenario, performance deficits would occur. The
idea of mainly demanding functions (e.g. strategy-
based thinking and acting) being impaired has also
been confirmed in a complex simulation approach,
trying to depict work-related impairments in a lab-
oratory setting (Streufert & Satish, 2005). To our
knowledge, this is the first time that dynamic aspects
of attentional control have been investigated in SAR
patients.
The second aim of the study was to explore associa-
tions between cognitive impairments in SAR patients
and allergy-related factors. On an intuitive level, dis-
ease factors that are most uncomfortable (i.e. sleeping
problems, severity of acute symptomatology) have
commonly been interpreted as the causing factors for
performance problems. In our study SAR subjects in-
deed experienced substantial sleeping problems and
were suffering from acute allergy-related symptoma-
tology with concurrent decreases in well-being.
However, in contrast to previous assumptions, these
variables did not explain the observed changes in cog-
nitive performance in our study. Neither several nights
of disturbed sleep nor unpleasant allergic symptoms
such as watery eyes or a congested nose accounted
for the observed slowing of information processing
and changes in conflict adaptation. Instead, particular
cognitive changes were found to be associated with
specific disease factors. The reduction in information
processing in both the sustained attention task and
the Simon task was associated with total IgE levels
whereas conflict-driven attention adjustment was asso-
ciated with state anxiety.
IgE has long been thought to play a prominent role
in the association of atopy and mood problems
(Timonen et al. 2003; Hashizume et al. 2005; Klokk
et al. 2007). However, to our knowledge, this is the
first demonstration of a relationship between increased
IgE levels and a decline in cognitive function (e.g. pro-
cessing speed), which warrants further investigation.
The mechanisms of how IgE affects cognitive processes
Table 3. Performance on the Simon task
SAR patients (n = 41) Healthy controls (n = 42)
On-season Off-season On-season Off-season
Trial type RT (ms) Error (%) RT (ms) Error (%) RT (ms) Error (%) RT (ms) Error (%)
All trials 519 (10) 3.5 (0.6) 490 (9) 3.1 (0.5) 471 (10) 4.0 (0.6) 469 (9) 3.9 (0.5)
Compatible (C) 510 (11) 2.5 (0.5) 480 (9) 2.2 (0.4) 462 (11) 2.7 (0.5) 458 (9) 2.6 (0.4)
Incompatible (I) 529 (11) 4.5 (0.8) 500 (9) 4.0 (0.7) 480 (10) 5.3 (0.8) 480 (9) 5.3 (0.7)
Compatibility effect (I – C) 19 (4) 2.0 (0.3) 20 (3) 1.8 (0.3) 18 (4) 2.6 (0.4) 21 (4) 2.7 (0.5)
cC 490 (10) 1.3 (0.4) 462 (9) 1.3 (0.3) 445 (10) 1.7 (0.4) 443 (8) 1.5 (0.3)
cI 542 (11) 7.3 (1.2) 511 (9) 5.3 (1.0) 491 (11) 7.4 (1.2) 489 (9) 7.4 (1.0)
iC 529 (11) 3.6 (0.6) 498 (9) 3.1 (0.7) 478 (11) 3.6 (0.6) 473 (9) 3.7 (0.6)
iI 516 (11) 1.7 (0.7) 489 (9) 2.7 (0.6) 468 (10) 3.3 (0.7) 470 (9) 3.1 (0.6)
Conflict adaptation effect
(cI – cC) – (iI – iC)
64 (5) 7.9 (1.0) 59 (6) 4.4 (1.1) 56 (5) 6.0 (1.2) 49 (5) 6.5 (1.2)
SAR, Seasonal allergic rhinitis; RT, reaction time.
Values are given as mean (standard error).
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are still unclear. Further evidence is necessary to deter-
mine whether total IgE is linked directly to cognition,
or mirrors a more complex pattern of behavior-
affecting immune parameters that are released in the
IgE-mediated immunological cascade (e.g. histamine,
cytokines). Based on recent research, increased
amounts of pro-inflammatory cytokines released in
the late phase of an allergic reaction (Ferreira, 2003)
are particularly predestined to cause behavioral and
cognitive changes because of their ability to cross the
blood–brain barrier (for review, see McAfoose &
Baune, 2009; Thayer & Sternberg, 2010; Capuron &
Miller, 2011). Increased levels of pro-inflammatory
cytokines have been related to decrements in proces-
sing speed, executive function and memory in immu-
nologically challenged and unchallenged healthy
populations and also in conditions of autoimmune dis-
eases (Krabbe et al. 2005; Marsland et al. 2006; Heesen
et al. 2010). In our study, SAR patients had a mean of
16 days of suffering from allergy symptoms prior to
the on-season testing session. Thus, initiation of the al-
lergic response, including activation of
pro-inflammatory cytokines, is likely and may have
contributed to the observed cognitive deficits during
the pollen season.
The detected alteration of conflict-driven control
adjustments in the current study was associated with
and paralleled by a change in state anxiety. A corre-
sponding relationship of attention control adjustment
and negative mood states has previously been shown
and discussed in the field of cognitive research (van
Steenbergen et al. 2010, 2012; Kuhbandner &
Zehetleitner, 2011; Padmala et al. 2011; Dreisbach &
Fischer, 2012). In this context, van Steenbergen and col-
leagues have linked alterations in conflict adaptation
with the mood-behavior model (MBM; Gendolla,
2000). The MBM posits that, based on its informative
value, negative mood is an indicator of insufficient sat-
isfaction with performance, and leads to increased de-
mand appraisals and therefore effort mobilization. In
line with this argument, such effort-increasing effects
of negative mood (i.e. state anxiety) could contribute
to the allergy-induced pattern of performance altera-
tions in our study. Alternatively, SAR patients might
somehow be more sensitive to aversive events during
acute allergy periods. Studies have shown that the ex-
perience of a cognitive conflict can serve as an aversive
signal that initiates the recruitment of adaptive control
(see Dreisbach & Fischer, 2012). A higher sensitivity for
those aversive signals might therefore account for both
the higher conflict adaptation effects and their corre-
spondence to state anxiety.
To summarize, our data show that SAR represents a
state that is linked to impairments in information pro-
cessing and changes in attentional control adjustments
that are, to some extent, not exclusively limited to per-
iods of symptomatic allergic reactions. These cognitive
alterations are widely unaffected by sleep impairments
and subjective symptom severity, but may be
influenced by mood and allergic inflammatory pro-
cesses. The detected effects are small to medium.
However, this range of effect sizes is not uncommon
in psychological research and instead elucidates the
complex interplay of several interacting factors in
human cognition, of which the present study only tar-
geted a limited number. Future studies should be
encouraged by our data to further examine the impact
of allergy on cognitive processes. In these studies, a lar-
ger sample size and direct measures of specific effort-
processing strategies during task performance should
be included. A comprehensive approach of methods
and paradigms under consideration of further mediat-
ing or underlying factors such as cytokines, stress re-
sponse and medication intake should be applied to
Fig. 2. Association between mean reaction time (RT in ms) in (a) the Continuous Performance Task (CPT) and (b) the Simon
task with rank-transformed total immunoglobulin E (RIgE) level at on-season testing. (c) Amount of conflict adaptation (CA)
as percentage error (PE) in the Simon task and the State Anxiety form of the Spielberger State–Trait Anxiety Inventory
(STAI-S) at on-season testing.
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fully understand SAR and its induced burden. Based
on that knowledge, future therapy strategies might
improve in a way that includes allergy symptoms in
their entirety. The current study has contributed to
this development by addressing the lack of knowledge
in allergy-induced cognitive changes and their
mechanisms.
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